Geron Corp. (NASDAQ:GERN) price closed lower on Monday, April 15, dropping -5.22% below its previous close.
A look at the daily price movement shows that the last close reads $3.64. The company’s 5Y monthly beta was ticking 0.61. Taking into account the 52-week price action we note that the stock hit a 52-week high of $4.05 and 52-week low of $1.64. The stock added 97.14% on its value in the past month.
Geron Corp., which has a market valuation of $2.03 billion, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give GERN a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that GERN’s price is at present 3.50% off the SMA20 and 35.76% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 60.83, with weekly volatility standing at 9.22%. The indicator jumps to 7.52% when calculated based on the past 30 days. Geron Corp. (NASDAQ:GERN)’s beta value is holding at 0.59, while the average true range (ATR) indicator is currently reading 0.26.
An analysis of the Geron Corp. (NASDAQ:GERN) stock in terms of its daily trading volume indicates that the 3-month average is 12.34 million.
Current records show that the company has 544.91M in outstanding shares. The insiders’ percentage holdings are 17.92% of outstanding shares while the percentage share held by institutions stands at 51.16%. But the 63.51% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
